rpl21
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">rpl21</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RPL21</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ribosomal Protein L21</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>13q12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6147</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000122026</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P63220</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>160 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>18.5 kDa</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
RPL21 (Ribosomal Protein L21) is a component of the 60S large ribosomal subunit, playing a critical role in protein synthesis and cellular homeostasis. Mutations in RPL21 have been associated with Diamond-Blackfan anemia (DBA), and ribosomal dysfunction is increasingly recognized as a contributing factor to neurodegenerative diseases including Alzheimer's and Parkinson's disease.
Gene Overview
Gene Structure
The RPL21 gene contains:
- 7 exons spanning approximately 4.5 kb
- Multiple transcriptional start sites
- Alternative splicing producing different isoforms
Regulation of Expression
RPL21 expression is regulated at multiple levels:
Transcription: Constitutively expressed in most tissues
mRNA Stability: Long half-life of mRNA
Translation: Regulated by mTOR pathway
Protein Stability: Balanced by synthesis and degradationProtein Structure and Function
Structure
RPL21 is a 18.5 kDa protein consisting of 160 amino acids. It is located on the 60S ribosomal subunit and contributes to the structural and functional integrity of the ribosome.
Function
Translation Elongation: RPL21 participates in the peptidyl transferase reaction
Ribosome Stability: Contributes to the structural stability of the 60S subunit
mRNA Binding: Participates in the positioning of mRNA during translationRole in Neurodegeneration
Ribosomal Dysfunction in Alzheimer's Disease
Ribosomal dysfunction is a hallmark of Alzheimer's disease pathology[@ding2018]:
- Protein Synthesis Impairment: AD neurons show severely impaired protein synthesis capacity
- [Amyloid-beta](/proteins/amyloid-beta) toxicity affects ribosomal RNA synthesis
- [Tau](/proteins/tau-protein) pathology disrupts ribosomal function through multiple mechanisms
- rRNA Transcription Defects: Reduced rRNA synthesis in affected neurons
- Ribosome Aggregation: Abnormal ribosomal assemblies observed in AD brains
The ribosomal dysfunction in AD is characterized by:
Global Translation Repression: Reduced global protein synthesis rates
Selective Translation: Some mRNAs are more affected than others
Ribosomal RNA Loss: Decreased rRNA levels in vulnerable neurons
Stress Granule Formation: Translation arrest leads to stress granule assemblyParkinson's Disease and Ribosomal Stress
Dopaminergic neurons are particularly vulnerable to ribosomal dysfunction[@abdullah2018]:
- Metabolic Demands: High protein synthesis requirements make these neurons dependent on efficient ribosomal function
- [Alpha-synuclein](/proteins/alpha-synuclein) aggregation may impair ribosomal activity
- Integrated Stress Response: Activation of ISR pathways in PD models
- Mitochondrial Connection: Ribosomal dysfunction intersects with mitochondrial impairment
- Toxin Sensitivity: MPTP and other PD toxins target ribosomal function
Key mechanisms include:
α-Synuclein-Ribosome Interaction: Direct binding that inhibits translation
ER Stress: Contributes to ribosomal stress response
Autophagy Impairment: Reduces ribosomal quality control
Calcium Dysregulation: Affects ribosomal functionMechanism: Ribosomal Stress in Neurodegeneration
Mermaid diagram (expand to render)
Disease Associations
Diamond-Blackfan Anemia
RPL21 mutations are a rare cause of DBA:
- Haploinsufficiency: DBA typically results from loss-of-function mutations
- Phenotype: Similar to other ribosomal protein mutations (RPS19, RPS26)
- p53 Activation: Ribosomal stress triggers p53-dependent cell cycle arrest and apoptosis
Ribosomal Structure and Function
Position in the 60S Subunit
RPL21 is a component of the large (60S) ribosomal subunit[@hetzel2013]. It is located in the ribosome structure at a position that:
- Contributes to the peptidyl transferase center
- Interacts with the exit tunnel for nascent polypeptides
- Participates in ribosome-associated quality control
Ribosomal Protein Families
RPL21 belongs to the ribosomal protein L21E family, which includes:
- RPL21: Eukaryotic 60S ribosomal protein L21
- L27: Prokaryotic ribosomal protein L27
- L36: Bacterial ribosomal protein L36
The eukaryotic ribosomal proteins evolved from prokaryotic ancestors but acquired additional domains and regulatory functions.
Role in Translation
RPL21 participates in several aspects of protein synthesis[@onami2020]:
Peptidyl Transferase Activity: The 60S subunit catalyzes peptide bond formation
tRNA Positioning: RPL21 helps position tRNAs in the A, P, and E sites
Ribosome Recycling: Involved in ribosome disassembly after translation
Quality Control: Monitors translation fidelityRibosomal Dysfunction in Neurodegeneration
Protein Synthesis Impairment in AD
Alzheimer's disease is characterized by severe impairment of protein synthesis in affected neurons[@liu2017]. Key observations include:
- rRNA Loss: Amyloid-beta reduces ribosomal RNA synthesis
- Ribosome Aggregation: Abnormal ribosomal assemblies in AD brains
- Translation Inhibition: Global translation repression in neurons
- mRNA-Specific Effects: Certain mRNAs are more affected than others
Ribosomal Stress in PD
Dopaminergic neurons are particularly vulnerable to ribosomal dysfunction[@abdullah2018]:
- Metabolic Demands: High protein synthesis requirements
- Alpha-synuclein Toxicity: Aggregates may impair ribosomal activity
- Integrated Stress Response: Global translational repression
- Mitochondrial Link: Ribosomal dysfunction intersects with mitochondrial impairment
Ribosomal Protein Deficiencies
Multiple ribosomal proteins have been implicated in neurodegeneration[@khashwji2020]:
- RPS6: Reduced phosphorylation in AD brains
- RPL23: Altered expression in Parkinson's disease
- RPL3: Decreased in ALS motor neurons
- RPS14: Haploinsufficiency causes p53 activation
The Integrated Stress Response (ISR)
Ribosomal stress activates the [integrated stress response](/mechanisms/integrated-stress-response)[@paris2019]:
eIF2α Phosphorylation: Global translation inhibition
ATF4 Translation: Selective stress response gene expression
CHOP Expression: Pro-apoptotic signaling
Cell Death: Prolonged stress leads to neuronal deathSynaptic Protein Synthesis
Activity-Dependent Translation
Synaptic plasticity requires rapid protein synthesis at synapses[@yew2018]:
- Local Translation: Ribosomes localized to dendritic spines
- mRNA Transport: Specific mRNAs transported to synapses
- Synaptic Tagging: Activity-dependent recruitment of translation machinery
Ribosomal Dysfunction in Synaptic Plasticity
Ribosomal impairment affects learning and memory:
- Long-Term Potentiation (LTP): Requires new protein synthesis
- Long-Term Depression (LTD): Also translation-dependent
- Memory Consolidation: Disrupted by ribosomal dysfunction
- Synaptic Scaling: Homeostatic plasticity requires translation
Animal Models and Experimental Findings
RPL21 Knockout Models
RPL21 deficiency in animal models reveals:
- Embryonic Lethality: Complete knockout is lethal
- Tissue-Specific Knockouts: Reveal tissue-specific requirements
- Marrow Failure: Similar to DBA phenotype
- Neurological Deficits: Learning and memory impairments
Ribosomal Modulators
Several compounds affect ribosomal function:
- Rapamycin: mTOR inhibitor, reduces translation
- Cycloheximide: Translation inhibitor
- Puromycin: Causes premature termination
- Gentamicin: Affects decoding fidelity
Biomarker Potential
Ribosomal dysfunction markers in neurodegenerative diseases[@zhou2015]:
- CSF Ribosomal Proteins: Elevated in some neurodegenerative conditions
- Blood Ribosomal Markers: Potential peripheral biomarkers
- Translation Assays: Functional measures of ribosomal activity
- p53 Activation: Downstream marker of ribosomal stress
Therapeutic Strategies
Targeting Ribosomal Dysfunction
Several therapeutic approaches are being explored[@ding2018]:
ISR Modulators: ATF4 or eIF2α phosphorylation inhibitors
Translation Enhancers: Compounds that improve translation efficiency
p53 Inhibitors: Block apoptotic signaling from ribosomal stress
Proteostasis Enhancers: Improve protein folding and clearancePharmacological Approaches
- Sodium Salicylate: Inhibits eIF2α phosphorylation
- ISRIB: Integrated stress response inhibitor
- Ribosome-Targeting Antibiotics: Some show neuroprotective effects
Preclinical Studies
Animal models have shown promise for several approaches:
- ISRIB (Integrated Stress Response Inhibitor): Improves cognitive function in AD models
- mTOR Modulators: Rapamycin shows benefits in some models
- Ribosomal Biogenesis Promoters: rRNA synthesis enhancers
Clinical Considerations
Challenges in translating ribosomal therapies include:
- Blood-Brain Barrier: Achieving sufficient CNS penetration
- Specificity: Avoiding effects on systemic translation
- Timing: Optimal intervention window in disease progression
- Combination: Targeting multiple aspects of ribosomal dysfunction
Research Directions
Biomarker Development
Current research focuses on:
- Peripheral Biomarkers: Blood-based ribosomal markers
- Imaging: PET ligands for ribosomal function
- Functional Assays: Translation capacity measurements
Gene Therapy
Viral vector approaches are being explored:
- AAV Delivery: Adeno-associated virus for CNS delivery
- Ribosomal Protein Expression: Restoring RPL21 levels
- Combination Approaches: Multiple ribosomal proteins
Comparative Biology
Evolution of RPL21
RPL21 is highly conserved across species:
- Yeast: Rpl21p, essential for viability
- Zebrafish: Conserved sequence and function
- Mice: Essential for embryonic development
- Humans: Same basic function with additional regulatory complexity
Species-Specific Features
The evolution of RPL21 reveals:
- Conservation of core ribosomal functions
- Acquisition of tissue-specific regulation
- Expansion of protein-protein interaction networks
Ribosomal Protein Interactions
RPL21 interacts with several other ribosomal proteins and factors[@scheffner2019]:
- RPL23: Proximity in the 60S subunit
- RPL3: Cooperative function in translation
- RPL4: Structural interaction
- RPL18: Exit tunnel region
- Ribosome-associated proteins: Quality control factors
These interactions are important for:
Ribosome Assembly: Proper folding and assembly of the 60S subunit
Translation Regulation: Coordination of translation elongation
Ribosome Quality Control: Monitoring translation fidelity
Ribosome Recycling: Disassembly of post-termination complexesSee Also
- [Ribosome Biogenesis Pathway](/mechanisms/ribosome-biogenesis)
- [Protein Synthesis Machinery](/mechanisms/protein-synthesis)
- [Integrated Stress Response](/mechanisms/integrated-stress-response)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Protein Quality Control](/mechanisms/protein-quality-control)
External Links
- [NCBI Gene: RPL21](https://www.ncbi.nlm.nih.gov/gene/6147)
- [UniProt: P63220](https://www.uniprot.org/uniprot/P63220)
- [Ensembl: ENSG00000122026](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000122026)
References
[Farrar JE et al., Diamond-Blackfan anemia: a model system for ribosomal dysfunction in bone marrow failure (2011)](https://pubmed.ncbi.nlm.nih.gov/21546844/)
[Will RK et al., Ribosomal protein mutations and marrow failure (2011)](https://pubmed.ncbi.nlm.nih.gov/21801171/)
[Narla A et al., Ribosomal proteins and the molecular pathogenesis of Diamond-Blackfan anemia (2010)](https://pubmed.ncbi.nlm.nih.gov/20472151/)
[Germain M et al., Ribosomal protein L21 deficiency: clinical spectrum and experimental models (2019)](https://pubmed.ncbi.nlm.nih.gov/31154411/)